Literature DB >> 16829708

Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity.

Toru Takeuchi1, Osamu Tsutsumi, Yumiko Ikezuki, Yoshimasa Kamei, Yutaka Osuga, Toshihiro Fujiwara, Yasushi Takai, Mikio Momoeda, Tetsu Yano, Yuji Taketani.   

Abstract

This study was performed to investigate the effect of androgen on the metabolism of bisphenol A (BPA), an endocrine disruptor, in order to clarify the mechanism of the higher levels of serum BPA in men and hyperandrogenemic women compared with normal women. Castrated female rats (OVX) were subcutaneously injected with testosterone propionate (TP) (0.01, 0.1, and 1 mg) every day for 2 weeks. Serum BPA concentrations in OVX rats showed a TP dose-dependent increase and were significantly higher at 0.1 and 1.0 mg of TP. The enzyme reaction of BPA glucuronidation in the rat liver microsomes showed that the ratio of glucuronide in the OVX rats was significantly reduced in a TP dose-dependent manner. Analysis of the mRNA expression of UDP-glucuronosyltransferase 2B1 (UGT2B1) by real-time quantitative RT-PCR revealed that the relative expression level of UGT2B1 mRNA showed a TP dose-dependent decrease. The results of enzyme analyses demonstrated that the ratio of BPA glucuronidation and the expression level of UGT2B1 mRNA were significantly lower under the hyperandrogenemic conditions. The clearance of BPA may be slowed in a TP dose-dependent manner, resulting in an increase of serum BPA concentration under hyperandrogenemic conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16829708     DOI: 10.1507/endocrj.k06-032

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  22 in total

Review 1.  Industrial endocrine disruptors and polycystic ovary syndrome.

Authors:  E Palioura; E Diamanti-Kandarakis
Journal:  J Endocrinol Invest       Date:  2013-12       Impact factor: 4.256

Review 2.  Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?

Authors:  Emily S Barrett; Marissa Sobolewski
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

Review 3.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

Review 4.  Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A.

Authors:  Laura N Vandenberg; Ibrahim Chahoud; Jerrold J Heindel; Vasantha Padmanabhan; Francisco J R Paumgartten; Gilbert Schoenfelder
Journal:  Environ Health Perspect       Date:  2010-03-23       Impact factor: 9.031

5.  No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24h after administration in neonatal female mice.

Authors:  Julia A Taylor; Wade V Welshons; Frederick S Vom Saal
Journal:  Reprod Toxicol       Date:  2008-01-17       Impact factor: 3.143

Review 6.  Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing.

Authors:  D Andrew Crain; Sarah J Janssen; Thea M Edwards; Jerrold Heindel; Shuk-mei Ho; Patricia Hunt; Taisen Iguchi; Anders Juul; John A McLachlan; Jackie Schwartz; Niels Skakkebaek; Ana M Soto; Shanna Swan; Cheryl Walker; Teresa K Woodruff; Tracey J Woodruff; Linda C Giudice; Louis J Guillette
Journal:  Fertil Steril       Date:  2008-10       Impact factor: 7.329

Review 7.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement.

Authors:  Evanthia Diamanti-Kandarakis; Jean-Pierre Bourguignon; Linda C Giudice; Russ Hauser; Gail S Prins; Ana M Soto; R Thomas Zoeller; Andrea C Gore
Journal:  Endocr Rev       Date:  2009-06       Impact factor: 19.871

Review 8.  In vivo effects of bisphenol A in laboratory rodent studies.

Authors:  Catherine A Richter; Linda S Birnbaum; Francesca Farabollini; Retha R Newbold; Beverly S Rubin; Chris E Talsness; John G Vandenbergh; Debby R Walser-Kuntz; Frederick S vom Saal
Journal:  Reprod Toxicol       Date:  2007-06-26       Impact factor: 3.143

Review 9.  Bisphenol-A and disparities in birth outcomes: a review and directions for future research.

Authors:  N Ranjit; K Siefert; V Padmanabhan
Journal:  J Perinatol       Date:  2009-07-09       Impact factor: 2.521

Review 10.  Sheep models of polycystic ovary syndrome phenotype.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.